Postoperative CD Reprogression Unrelated to Preoperative Phenotype Postoperative reprogression to stricturing or penetrating complications is not linked to preoperative disease phenotype in CD ileocecal resection.

Preoperative disease phenotype does not predict postoperative reprogression in #CrohnDisease.
www.gastroenterologyadvisor.com/news/postoperative-cd-re...

JAMA Clinical Guidelines Synopsis: Management of Crohn Disease in Adults, published online April 8, 2026. Guideline title: Management of Crohn's Disease in Adults. Release date June 3, 2025. Prior version April 2018.

📊 JAMA Clinical Guidelines Synopsis: #CrohnDisease guidelines recommend fecal calprotectin for screening and monitoring, routine colonoscopy for colorectal cancer, and oral budesonide for induction in mild to moderate ileocecal disease.

ja.ma/4miZoEk

Preoperative and Postoperative TNFi Use in CD Associated With Improved Outcomes Perioperative TNF inhibitor use is associated with improved outcomes among patients with CD undergoing bowel resection.

Perioperative TNFi therapy is safe and efficacious for #CrohnDisease, reducing staged surgery and postoperative endoscopic recurrence without increasing complication risk.
www.gastroenterologyadvisor.com/news/preoperative-and-po...

JAMA Clinical Guidelines Synopsis: Management of Crohn Disease in Adults, published online April 8, 2026. Guideline title: Management of Crohn's Disease in Adults. Release date June 3, 2025. Prior version April 2018.

📊 JAMA Clinical Guidelines Synopsis: #CrohnDisease guidelines recommend fecal calprotectin for screening and monitoring, routine colonoscopy for colorectal cancer, and oral budesonide for induction in mild to moderate ileocecal disease.

ja.ma/47QA5ng

Analysis of the use of monoclonal antibodies in the treatment of Crohn’s disease Statement of Significance Despite clinical efficacy and safety, antibodies currently used for the treatment of Crohn’s disease have a number of limitations

Antibody Therapeutics (IF=4.5, Oxford University Press)
⚡ Review Highlight - Analysis of the use of monoclonal antibodies in the treatment of Crohn’s disease
academic.oup.com/abt/article/...
#Crohndisease #antibody #antibodytherapeutics #antibodydiscovery #antibodydevelopment

Research Article

Risk of Spondyloarthritis in Patients With Inflammatory Bowel Disease Receiving Treatment With Biologics or Janus Kinase Inhibitors

📖 www.jrheum.org/cgi/content/...

#CrohnDisease #UlcerativeColitis #InflammatoryBowelDisease #Spondyloarthritis

Hazard ratio chart showing lower/higher risk of VTE with different advanced therapies. TNF antagonists, Vedolizumab, IL-12/23 antagonists, IL-23 antagonists and JAK inhibitors are listed with hazard ratios and confidence intervals.

Safety of advanced therapies for #CrohnDisease—tumor necrosis factor antagonists, anti-integrins, interleukin inhibitors, and Janus kinase inhibitors—was comparable, with no significant differences in serious infection, VT, or cardiovascular event risk.

bit.ly/4rzRyaQ

Inflammatory Bowel Diseases Up Risk for Prostate Cancer Surgery Complications - Oncology Nurse Advisor Investigators analyzed IBD subtypes and their associated risks of radical prostatectomy complications among a cohort of patients with prostate cancer to fill a knowledge gap.

Men with #CrohnDisease or ulcerative colitis have worse in-hospital outcomes after radical prostatectomy for #prostatecancer compared with men free from these IBD, a recent study From @renalurologynews.bsky.social finds.

https://bit.ly/3XKtfdC

#pcsm

Crohn Disease: Early Diagnosis and Long-Term Treatment Guidelines Crohn disease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life.

#CrohnDisease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life. Read a review of guidelines for clinicians here⬇️ bit.ly/3KsMLbA

#MedSky #HCPsOnBluesky

Former SpaceX employee with Crohn’s disease sues Elon Musk for being fired over using bathroom frequently - Times of India US News: A former SpaceX employee, Douglas Altshuler, is suing the company, alleging he was wrongfully terminated due to his Crohn's disease, which required fr

A former employee of Elon Musk’s SpaceX is suing the company for firing him over frequent bathroom use caused by a chronic medical condition - Crohn’s disease.
timesofindia.indiatimes.com/articleshow/...
#ostomy #stoma #Crohndisease

#2 How Do You Like Your IBD Medication Served... Oral, IV or Injection? Wrestling the Octopus (IBD) · Episode

Episode 2 of our #IBD patient podcast, Wrestling the Octopus is live!

What factors should IBD healthcare professionals take into account when helping patients choose how they take their drugs: orally, IV or injections?

Listen here: open.spotify.com/epi...

#crohns #crohndisease #ulcerativecolitis

Little 5K run today. It’s been 1 year that I’m going to the gym and it changed my life. It helped me physically and psychologically. It’s now part of the drugs I have to take to try to keep #crohns asleep.

Petite course de 5K aujourd’hui #crohndisease #IBD #UC #crohn #RCH #MICI #sport #running

26/25 #crohns #chronicillness #chronicdisease #ulcerativecolitis #UC #crohndisease #IBD #MICI #rectocolitehemorragique #crohn #story #lifestory #testimony #motivation #livingwithibd #guts #selfestim #sport #gym #exercise #lifejourney #illness #disease #incurable #depression #onestepatatime

2 pictures, 2 completely different life.
Hi, there I’m Tibo, I have IBD and I’m here to to share about my turbulent relationship with my guts, the bad and the good (wait is there any good?). #IBD #crohns #crohndisease #uc #ulceritivecolitis #chronicilness #health #mentalhealth 1/25

DEFINE_ME

More #TL1A inhibitor data this week, with results of duvakitug mAB for #UlcerativeColitis; and #CrohnDisease Sanofi
lnkd.in/ejZrZyvU

This class of drug has potential to reverse fibrosis;
www.mucosalimmunology.org/article/S193...

Use of cross-sectional imaging is growing for the clinical management of strictures in #Crohndisease & in the development of antifibrotic therapies

Link ⬇️ to a great paper that gives an overview of quantitative imaging methods in differentiating inflammatory/fibrotic components of strictures

CONGRATS to @VeronikaBosak for the presentation award at PhD conference @Science_MEDMUNI #iPSC #Organoid #Crohndisease @FNUSA_ICRC #CTM